Preclinical Evaluation Assesses [11C]Onalespib for Cancer and Brain PET Imaging
A preclinical evaluation of the radiolabelled Hsp90 inhibitor onalespib demonstrated tumour binding but revealed rapid metabolism and negligible brain penetration.
A preclinical evaluation of the radiolabelled Hsp90 inhibitor onalespib demonstrated tumour binding but revealed rapid metabolism and negligible brain penetration.
Researchers validated 5-MOP, a tritium-labeled radioligand that binds CSF1R with 9.8 nM affinity and far greater kinase selectivity than the ...
A newly synthesized PET tracer, 4-N-FDG-PBA, showed low liver background and GLUT-independent tumor uptake in preclinical mouse and cell studies.
A prospective study finds that 68Ga-HER2 PET/CT scans after just two cycles of neoadjuvant therapy can predict which HER2-positive breast ...
An AI-assisted design pipeline produced the gallium-68 PET tracer Ga-DOTA-FZPF, which targets PARP-1 and has now completed a first-in-human evaluation ...
Researchers have engineered a glycosylated derivative of the common PET tracer FDG that is imported exclusively by the bacterial phosphotransferase ...
In groundbreaking developments within the field of neuroimaging, a recent study introduces a novel radiotracer that has shown promise in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.